검색
Nuvation Bio Inc
NUVB관심 목록에 추가
4.590USD
-0.170-3.57%
종가 11-02 16:00（ET）
1.61B시가총액
손실P/E TTM
Nuvation Bio Inc 정보 회사
Nuvation Bio Inc. is a global biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. Its programs include taletrectinib (ROS1 inhibitor), safusidenib (mIDH1 inhibitor), NUV-1511 (drug-drug conjugate), and NUV-868 (BET inhibitor). The Company's Taletrectinib is an oral, potent, central nervous system-active, selective, ROS1 inhibitor specifically designed for the treatment of patients with ROS1-positive (ROS1+) non-small cell lung cancer (NSCLC). Safusidenib is a novel, oral, potent, brain penetrant, targeted inhibitor of mutant isocitrate dehydrogenase 1(mIDH1). NUV-1511, a clinical-stage drug-drug conjugate (DDC), fuses a targeting agent to a widely used chemotherapy agent. Its NUV-868 is a BD2-selective, oral, small molecule bromodomain and extra-terminal (BET) inhibitor that inhibits BRD4.
Nuvation Bio Inc 프로필
종목 코드 NUVB
회사 이름Nuvation Bio Inc
상장일Jul 01, 2020
CEOHung (David T)
직원 수220
유형Ordinary Share
회계 연도 종료Jul 01
주소1500 Broadway
도시NEW YORK
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호10036
전화13322086102
웹사이트https://www.nuvationbio.com/
종목 코드 NUVB
상장일Jul 01, 2020
CEOHung (David T)
Nuvation Bio Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. David T. Hung, M.D.
Dr. David T. Hung, M.D.
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
59.28M
-1.69%
Dr. Robert Mashal, M.D.
Dr. Robert Mashal, M.D.
Independent Director
Independent Director
200.00K
+50.00%
Mr. Kim D. Blickenstaff
Mr. Kim D. Blickenstaff
Independent Director
Independent Director
172.19K
--
Ms. Colleen Sjogren
Ms. Colleen Sjogren
Chief Commercial Officer
Chief Commercial Officer
78.00K
+64.10%
Mr. Moses Makunje, CPA
Mr. Moses Makunje, CPA
Principal Accounting Officer, Vice President - Finance
Principal Accounting Officer, Vice President - Finance
61.37K
--
Mr. Philippe Sauvage
Mr. Philippe Sauvage
Chief Financial Officer and Principal Financial Officer
Chief Financial Officer and Principal Financial Officer
52.67K
+75.94%
Ms. Kerry A. Wentworth
Ms. Kerry A. Wentworth
Chief Regulatory Officer
Chief Regulatory Officer
50.00K
--
Ms. Stacy Markel
Ms. Stacy Markel
Chief People Officer
Chief People Officer
10.00K
--
Mr. Robert B. (Rob) Bazemore, Jr.
Mr. Robert B. (Rob) Bazemore, Jr.
Lead Independent Director
Lead Independent Director
5.00K
--
Dr. Gary Hattersley, Ph.D.
Dr. Gary Hattersley, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. David T. Hung, M.D.
Dr. David T. Hung, M.D.
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
59.28M
-1.69%
Dr. Robert Mashal, M.D.
Dr. Robert Mashal, M.D.
Independent Director
Independent Director
200.00K
+50.00%
Mr. Kim D. Blickenstaff
Mr. Kim D. Blickenstaff
Independent Director
Independent Director
172.19K
--
Ms. Colleen Sjogren
Ms. Colleen Sjogren
Chief Commercial Officer
Chief Commercial Officer
78.00K
+64.10%
Mr. Moses Makunje, CPA
Mr. Moses Makunje, CPA
Principal Accounting Officer, Vice President - Finance
Principal Accounting Officer, Vice President - Finance
61.37K
--
Mr. Philippe Sauvage
Mr. Philippe Sauvage
Chief Financial Officer and Principal Financial Officer
Chief Financial Officer and Principal Financial Officer
52.67K
+75.94%
자주 묻는 질문
Nuvation Bio Inc의 상위 5대 주주는 누구인가요?
Nuvation Bio Inc의 상위 5대 주주는 다음과 같습니다: Dr. David T. Hung, M.D.
Nuvation Bio Inc(NUVB)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Nuvation Bio Inc의 주식을 보유한 기관은 총 421곳이며, 이들이 보유한 주식의 총 가치는 약 228.36M로 전체 발행 주식의 65.58%를 차지합니다. 이는 2025Q4 대비 -32847901.00 증가한 수치입니다.